Literature DB >> 6265347

Sendai virus infected cells are readily cytolysed by guinea-pig complement without antibody.

H Okada, N Okada.   

Abstract

HeLa cells infected with Sendai virus (SV) acquired the ability to activate the alternative pathway (AP) of guinea-pig complement without antibody reaction. For induction of complement activating ability (CAA), at least 2 hr incubation of the infected cells was required. However, ultraviolet (UV)-irradiation (8400 erg/mm2) of SV did not impair the inducibility of CAA and 51Cr-labelled HeLa cells infected with UV-irradiated SV (UV-SV) became readily cytolysed by C4-deficient guinea-pig complement without antigen-antibody reaction. This phenomenon may represent a primary in vivo defence mechanism against SV infection by eliminating the virus-infected cells via activation of complement on the cell surface. Although SV-infected HeLa cells activated the AP of guinea-pig complement, they did not activate the AP of human or mouse complement. The species restriction in the CAA induced by SV infection may result in different pathological manifestations in virus-infected animals and may affect their susceptibility to this type of infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265347      PMCID: PMC1555019     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Activation of complement by spontaneous leukemic cells of AKR mice.

Authors:  N Okada; H Okada
Journal:  Int J Cancer       Date:  1978-09-15       Impact factor: 7.396

2.  Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  Effect of trypsin on the infectivity of Sendai virus grown in several host cells.

Authors:  H Shibuta
Journal:  Jpn J Microbiol       Date:  1972-05

4.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

5.  Rosette formation of human erythrocytes on cultured cells of tumour origin and activation of complement by cell membrane.

Authors:  H Okada; T Baba
Journal:  Nature       Date:  1974-04-05       Impact factor: 49.962

6.  Modification in growth of transplantable rat tumors exposed to Friend virus.

Authors:  H Kobayashi; F Sendo; T Shirai; H Kaji; T Kodama
Journal:  J Natl Cancer Inst       Date:  1969-03       Impact factor: 13.506

7.  The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.

Authors:  P J Lachmann; L Halbwachs
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

8.  Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

9.  Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.

Authors:  N R Cooper; F C Jensen; R M Welsh; M B Oldstone
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

10.  In vitro studies of complement function in sera of C4-deficient guinea pigs.

Authors:  M M Frank; J May; T Gaither; L Ellman
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  4 in total

1.  Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.

Authors:  J A van Strijp; K P van Kessel; L A Miltenburg; A C Fluit; J Verhoef
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.

Authors:  C R Lambre; M Thibon; S Le Maho; G Di Bella
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

3.  Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement.

Authors:  H Okada; H Tanaka; N Okada
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

4.  Tumor cells treated with vaccinia virus can activate the alternative pathway of mouse complement.

Authors:  N Wakamiya; N Okada; Y L Wang; T Ito; S Ueda; S Kato; H Okada
Journal:  Jpn J Cancer Res       Date:  1989-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.